Previous Episode: #108 - ALEX BLANIA
Next Episode: #110 - NAIT JONES

Matt is a researcher and professor at the University of Washington School of Medicine. His research interests are focused on basic mechanisms of aging in order to facilitate translational interventions that promote healthspan and improve quality of life. Matt is co-Director of the Dog Aging Project, as well as the founding Director of the Healthy Aging and Longevity Research Institute at the University of Washington, Director of the Nathan Shock Center of Excellence in the Basic Biology of Aging, and Director of the Biological Mechanisms of Healthy Aging Training Program. He previously served as President of the American Aging Association and has served on their Executive Committee and Board of Directors since 2012. Follow Matt on Twitter @mkaeberlein.


[2:18] - Matt’s journey through academia and discovery of longevity research


[9:26] - The importance of being patient with personal development, considering future life extension developments


[16:21] - Forces that limit longevity, personal choices to extend life expectancy


[26:36] - Why Matt is increasingly optimistic about longevity developments


[35:58] - Comparing the ROI for investing in longevity research vs. cancer research


[45:30] - The Dog Aging Project


[50:59] - Matt’s research on rapamycin and his hope for its future applications in both humans and animals


---


Support the show by checking out my sponsors:


Join Levels and get personalized insights to learn about your metabolic health. Go to https://levels.link/jake.


---


https://homeofjake.com

Twitter Mentions